Non-ischemic RVO-ME treated with ranibizumab plus dexamethasone implant achieved superior BCVA improvement versus ranibizumab alone at 3 months and remained significantly better through 9 months.
MedPage Today on MSN
IL-6 inhibitor shows promise in diabetic macular edema
Adding vamikibart to VEGF inhibition improved visual acuity and retinal anatomy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results